- Manage TDP’s data-driven consulting services, serving a global client base with aggregate sales exceeding $300 billion.- Developed and refined TDP's business model to align with client needs and market demands.- Led the execution of $500 million in acquisitions within the Biotech/Pharma and Construction sectors.- Facilitated tens of millions in corporate venture capital (CVC) investments and startup-corporate R&D joint ventures in areas such as AI, Motors, and Rapid Diagnostics.- Developed comprehensive market entry strategies and advanced data modeling techniques to support client growth and innovation.

- Created the BYU Biotech Consulting Group with peers and faculty- Generated biosimilars business strategy for large global pharmaceutical company, including novel business modeling

- Conducted biomedical informatics research on multiple sclerosis (MS), advancing knowledge in the field of neurological disorders.- Led a Phenome-Wide Association Study (PheWAS) on the Y chromosome and its relationship to MS, providing novel insights into genetic factors influencing the disease.- Published research on the genetic relationship between mental disorders and MS, contributing to the scientific community's understanding of comorbid conditions (see publications below in profile).

- Led a research project on metabolic screening of Nicotiana attenuata, providing critical insights into plant metabolism.- Performed metabolic extractions and analyzed results using Liquid Chromatography-Mass Spectrometry (LC-MS), ensuring precise and reliable data.- Conducted Quantitative Trait Loci (QTL) analyses to uncover genetic relationships associated with ecologically relevant phenotypic variations, contributing to the understanding of plant defense genetics.